Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

BACKGROUND: The best strategy to protect individuals against meningococcal disease is to immunize against multiple serogroups. Immunogenicity, antibody persistence, and safety of the EU-licensed meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) were evaluated in healthy participants a...

Descripción completa

Detalles Bibliográficos
Autores principales: Borja-Tabora, Charissa, Montalban, Cecilia, Memish, Ziad A, Van der Wielen, Marie, Bianco, Veronique, Boutriau, Dominique, Miller, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599520/
https://www.ncbi.nlm.nih.gov/pubmed/23510357
http://dx.doi.org/10.1186/1471-2334-13-116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599520/
https://www.ncbi.nlm.nih.gov/pubmed/23510357
http://dx.doi.org/10.1186/1471-2334-13-116

Ejemplares similares